Clinical trial No longer in our active list Interventional Ages 18 and up

Single-stage surgery with antibiotic-coated implants for hip joint infection prevention

Official title: Single-stage Surgery With Antibiotic-loaded Hydrogel Coated Implants Versus Two Stage Surgery for Secondary Prevention of Complex Chronic Periprosthetic Hip Joint Infection SINBIOSE-H.

Run by Centre Hospitalier Universitaire de Saint Etienne · NCT04251377 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a single surgery using special antibiotic-coated implants can help people with hip joint infections recover faster and avoid complications compared to the usual two-surgery method.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment440 (estimated)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Academic / other
Locations14 sites (Amiens and 13 other locations)
Trial IDNCT04251377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with chronic periprosthetic hip joint infections who meet specific diagnostic criteria.

Probably not a fit

Patients with hypersensitivity to hydrogel components or those with a life expectancy significantly limited by other health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares a single-stage surgical approach using antibiotic-loaded hydrogel coated implants to the traditional two-stage surgery for patients with chronic periprosthetic hip joint infections. The single-stage method aims to reduce the time to rehabilitation and minimize complications associated with prolonged antibiotic treatment and multiple surgeries. Patients will undergo implant removal followed by immediate re-implantation of a new prosthesis during the same procedure. The study seeks to evaluate the effectiveness and safety of this innovative approach in preventing infection recurrence.

Why it matters

Potential benefit: If successful, this approach could significantly reduce recovery time and complications for patients suffering from hip prosthesis infections.

How similar studies have gone: While the two-stage surgery is a well-established protocol, the single-stage approach is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Social security affiliation
* Signed informed consent
* Chronic periprosthetic hip joint infection defined according to the Musculoskeletal Infection Society criteria :
* Two positive periprosthetic cultures with phenotypically identical organisms
* or a sinus tract communicating with the joint,
* or having 3 of 5 minor criteria:

  * Elevated serum C-reactive protein (CRP) and Erythrocyte Sedimentation Rate (ESR);
  * Elevated synovial fluid White Blood Cell (WBC) count or change of ++ on leukocyte esterase test strip;
  * Elevated synovial fluid Polymorphonuclear Neutrophil Percentage (PMN%);
  * Positive histological analysis of periprosthetic tissue;
  * A single positive culture.

Exclusion Criteria:

* Patients with hypersensitivity to hydrogel components (hyaluronic acid and/or poly-lactic acid) known of Defensive Antibacterial Coating (DAC)®
* Pregnancy or positive pregnancy test (performed in women of childbearing age before inclusion)
* Life expectancy \< 3 months
* Expected use of a cemented implant by the surgical team (for the treatment surgical protocol)
* Unable to give informed consent
* Patients under guardianship or curators
* Refusal to participate

Where it's running

  • Chu Saint-Etienne
    Saint-etienne, France
    Recruiting
  • CHU Amiens
    Amiens, France
    Not yet recruiting
  • CHU Bordeaux
    Bordeaux, France
    Not yet recruiting
  • CHU Caen
    Caen, France
    Not yet recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, France
    Not yet recruiting
  • CHU Dijon
    Dijon, France
    Not yet recruiting
Show 8 more locations
  • CHU Lille
    Lille, France
    Not yet recruiting
  • HCL - Hôpital de la Croix Rousse
    Lyon, France
    Not yet recruiting
  • HCL - Hôpital Edouard Herriot
    Lyon, France
    Not yet recruiting
  • CHU Marseille
    Marseille, France
    Not yet recruiting
  • CHU Nancy
    Nancy, France
    Not yet recruiting
  • CHU Nantes
    Nantes, France
    Not yet recruiting
  • CHU Nice
    Nice, France
    Not yet recruiting
  • CHU Toulouse
    Toulouse, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.